Record results for Zip Co sent the share price skyrocketing. Seneca's Luke Laretive explains why an expanding US business is the key driver.

Resilient global and Australian growth is being tested by renewed geopolitical tensions and stubborn inflation

Evolution posts a third straight record result. Fidelity's Cameron Taylor on the dividend lift, capex timing and gold's wild ride.

A legal-assets fund manager trading below half book value, with improving fee economics, rising cash conversion and near-term catalysts.

Adam Grotzinger says core inflation should be contained and rates on hold, and that's created opportunities across credit markets.

High growth and international shares options delivered up to 23.2% in FY26, but taking more risk comes with a catch.

I take a closer look at the impact of volatility drag on investor outcomes and some simple steps that can be taken to manage such risks.

Cost-of-living pressures are playing into Breville's hands, yet Airlie sees an untapped market that could power its next leg of growth.

The copper transition is no longer a story about the future. BHP's CFO breaks down what it means for returns and growth from here.

Copper has catapulted the mining giant to a bigger dividend and strong numbers. Here's how we saw the results.

A soft US CPI, growing signs of Australian household stress and a gold position worth revisiting. Cameron Gleeson on the week in markets.

The CEO's view on what drove HUB24's $18.9 billion of net inflows, the SaaSpocalypse and the road to double-digit market share.

Adam Dawes and Andrew Wielandt weigh in on six thematic ETFs across technology, semiconductors, biotech, bitcoin and Australian property.

In this panel special, we discuss the upcoming hybrids phaseout and explain how investors need to think about a new era for fixed income.

CSL beat expectations, guided to 5% earnings growth, and sent shares surging - but plenty of questions remain for the leaderless biotech.

In a fracturing world, gold’s appeal increasingly reflects how investors value diversification, resilience and trust.

Record contracts, bigger dividends and double-digit earnings and revenue growth underpin a big result for the medtech company.

BHP's copper pivot has hit an inflection point.